Noblewell
11
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
1 terminated/withdrawn out of 11 trials
90.0%
+3.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
Role: collaborator
An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
Role: collaborator
Efficacy of Amantadine Treatment in COVID-19 Patients
Role: lead
Surgical Resection of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction
Role: lead
Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study
Role: lead
Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure
Role: lead
Surgical Removal of Carotid Body in Patients With Systolic Heart Failure
Role: lead
Carotid Body Removal for the Treatment of Resistant Hypertension
Role: lead
Carotid Ultrasound Study
Role: lead
Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study
Role: lead
Study on Reflex Response During Temporary Stimulation and Inhibition of Chemoreceptors of Carotid Bodies - a Pilot Study
Role: lead
All 11 trials loaded